Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

suPAR: The unspecific marker for disease presence, severity and prognosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Dokumenter

DOI

  1. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Efficacy of mecillinam against clinical multidrug-resistant Escherichia coli in a murine urinary tract infection model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Leukocyte Activation Profile Assessed by Raman Spectroscopy Helps Diagnosing Infection and Sepsis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. An open label trial of anakinra to prevent respiratory failure in COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Investigation of biomarkers that can promptly predict unfavourable outcome of critically illness is an emerging necessity taking into consideration the need for early intervention, the shortage of available beds in intensive care units and the considerable cost of hospitalisation. The most promising biomarker is soluble urokinase-type plasminogen activator receptor (suPAR). Three studies in large populations of critically ill patients and patients admitted to the emergency department have shown that concentrations >12ng/mL can safely predict unfavourable outcome. This review presents a thorough analysis of the data from these studies.

OriginalsprogEngelsk
TidsskriftInternational Journal of Antimicrobial Agents
Vol/bind41
Udgave nummer1
Sider (fra-til)s33-s34
ISSN0924-8579
DOI
StatusUdgivet - dec. 2015

Mest downloadede publikationer

Ingen data tilgængelig

ID: 45835451